Organigram reported strong growth across all major financial and operational metrics in its first quarter ended December 31, 2025. The company stated that it delivered significant year-over-year gains in revenue, profitability, and production efficiency, while expanding its U.S. footprint and advancing key innovations in cultivation.
Click here for the full story.
Weekly Update – Top Cannabis News Stories
1 | Canopy Growth reports Q3 Fiscal 2026 financial results – Double digit net revenue growth
2 | High Tide opens new Canna Cabana in Scarborough
3 | Curaleaf announces refinancing with proposed US$500 million senior secured notes offering
4 | Cannabix Technologies launches non-brokered private placement up to C$1,000,000
Top Cannabis Stocks Feb. 06 to Feb. 12, 2026
1. T.CURA | 9,198 views | Curaleaf Holdings Inc.
2. T.TLRY | 2,743 views | Tilray Brands Inc.
3. T.LABS | 1,984 views | Medipharm Labs Corp.
4. C.TGIF | 539 views | 1933 Industries Inc.
5. T.OGI | 340 views | Organigram Global Inc.
6. T.ACB | 336 views | Aurora Cannabis Inc.
Stockhouse does not provide investment advice or recommendations. All investment decisions should be made based on your own research and consultation with a registered investment professional. The issuer is solely responsible for the accuracy of the information contained herein. For full disclaimer information, please click here.
